Hanall CEO donate 45,000 shares

Published: 2010-04-07 06:56:00

Updated: 2010-04-07 06:56:00

Kim Sung-wuk, CEO and president of Hanall BioPharma (formerly Hanall Pharm) donated 45,300 shares from his own stocks to employees, which accounted 1.13 percent of his total stock, or 230 million won.

Kim said that his decision to donate his shares is to boost the morale of employees and comme...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK